These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

462 related articles for article (PubMed ID: 12631373)

  • 1. Effect of icodextrin on volume status, blood pressure and echocardiographic parameters: a randomized study.
    Konings CJ; Kooman JP; Schonck M; Gladziwa U; Wirtz J; van den Wall Bake AW; Gerlag PG; Hoorntje SJ; Wolters J; van der Sande FM; Leunissen KM
    Kidney Int; 2003 Apr; 63(4):1556-63. PubMed ID: 12631373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of a favourable response to icodextrin in peritoneal dialysis patients with ultrafiltration failure.
    Wiggins KJ; Rumpsfeld M; Blizzard S; Johnson DW
    Nephrology (Carlton); 2005 Feb; 10(1):33-6. PubMed ID: 15705179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized controlled trial of icodextrin versus glucose containing peritoneal dialysis fluid.
    Lin A; Qian J; Li X; Yu X; Liu W; Sun Y; Chen N; Mei C;
    Clin J Am Soc Nephrol; 2009 Nov; 4(11):1799-804. PubMed ID: 19808224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of icodextrin in automated peritoneal dialysis on blood pressure and bioelectrical impedance analysis.
    Woodrow G; Oldroyd B; Stables G; Gibson J; Turney JH; Brownjohn AM
    Nephrol Dial Transplant; 2000 Jun; 15(6):862-6. PubMed ID: 10831642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Icodextrin improves the fluid status of peritoneal dialysis patients: results of a double-blind randomized controlled trial.
    Davies SJ; Woodrow G; Donovan K; Plum J; Williams P; Johansson AC; Bosselmann HP; Heimbürger O; Simonsen O; Davenport A; Tranaeus A; Divino Filho JC
    J Am Soc Nephrol; 2003 Sep; 14(9):2338-44. PubMed ID: 12937311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of twice-daily icodextrin administration on blood pressure and left ventricular mass in patients on continuous ambulatory peritoneal dialysis.
    Sav T; Oymak O; Inanc MT; Dogan A; Tokgoz B; Utas C
    Perit Dial Int; 2009; 29(4):443-9. PubMed ID: 19602610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Echocardiographic, electrocardiographic and blood pressure changes induced by icodextrin solution in diabetic patients on peritoneal dialysis.
    Paniagua R; Orihuela O; Ventura MD; Avila-Díaz M; Cisneros A; Vicenté-Martínez M; Furlong MD; García-González Z; Villanueva D; Prado-Uribe MD; Alcántara G; Amato D
    Kidney Int Suppl; 2008 Apr; (108):S125-30. PubMed ID: 18379535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of a dialysis solution with icodextrin on ultrafiltration and selected metabolic parameters in patients treated with peritoneal dialysis].
    Opatrná S; Racek J; Stehlík P; Senft V; Sefrna F; Topolcan O; Opatrný K
    Cas Lek Cesk; 2002 May; 141(9):281-5. PubMed ID: 12061197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An exploratory study of a novel peritoneal combination dialysate (1.36% glucose/7.5% icodextrin), demonstrating improved ultrafiltration compared to either component studied alone.
    Jenkins SB; Wilkie ME
    Perit Dial Int; 2003; 23(5):475-80. PubMed ID: 14604201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of a 7.5% icodextrin peritoneal dialysis solution in patients treated with automated peritoneal dialysis.
    Plum J; Gentile S; Verger C; Brunkhorst R; Bahner U; Faller B; Peeters J; Freida P; Struijk DG; Krediet RT; Grabensee B; Tranaeus A; Filho JC
    Am J Kidney Dis; 2002 Apr; 39(4):862-71. PubMed ID: 11920355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Automated peritoneal dialysis prescriptions for enhancing sodium and fluid removal: a predictive analysis of optimized, patient-specific dwell times for the day period.
    Akonur A; Guest S; Sloand JA; Leypoldt JK
    Perit Dial Int; 2013; 33(6):646-54. PubMed ID: 24335125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of icodextrin in peritoneal dialysis patients.
    Moberly JB; Mujais S; Gehr T; Hamburger R; Sprague S; Kucharski A; Reynolds R; Ogrinc F; Martis L; Wolfson M
    Kidney Int Suppl; 2002 Oct; (81):S23-33. PubMed ID: 12230479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluid status in CAPD patients is related to peritoneal transport and residual renal function: evidence from a longitudinal study.
    Konings CJ; Kooman JP; Schonck M; Struijk DG; Gladziwa U; Hoorntje SJ; van der Wall Bake AW; van der Sande FM; Leunissen KM
    Nephrol Dial Transplant; 2003 Apr; 18(4):797-803. PubMed ID: 12637651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation between peritoneal permeability and ultrafiltration volume with icodextrin-based peritoneal dialysis solution.
    Moriishi M; Kawanishi H; Watanabe H; Tsuchiya S
    Adv Perit Dial; 2004; 20():166-9. PubMed ID: 15384820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of the effectiveness, safety, and biocompatibility of icodextrin in automated peritoneal dialysis. The Dextrin in APD in Amsterdam (DIANA) Group.
    Posthuma N; ter Wee PM; Donker AJ; Oe PL; Peers EM; Verbrugh HA
    Perit Dial Int; 2000; 20 Suppl 2():S106-13. PubMed ID: 10911654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advanced glycosylation end-products in diabetic rats on peritoneal dialysis using various solutions.
    Lee JH; Reddy DK; Saran R; Moore HL; Twardowski ZJ; Nolph KD; Khanna R
    Perit Dial Int; 2000; 20(6):643-51. PubMed ID: 11216553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Icodextrin Solution on the Preservation of Residual Renal Function in Peritoneal Dialysis Patients: A Randomized Controlled Study.
    Chang TI; Ryu DR; Yoo TH; Kim HJ; Kang EW; Kim H; Chang JH; Kim DK; Moon SJ; Yoon SY; Han SH;
    Medicine (Baltimore); 2016 Mar; 95(13):e2991. PubMed ID: 27043667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nutritional effects of increasing dialysis dose by adding an icodextrin daytime dwell to Nocturnal Intermittent Peritoneal Dialysis (NIPD) in children.
    van Hoeck KJ; Rusthoven E; Vermeylen L; Vandesompel A; Marescau B; Lilien M; Schroder CH
    Nephrol Dial Transplant; 2003 Jul; 18(7):1383-7. PubMed ID: 12808177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Icodextrin with nitroprusside increases ultrafiltration and peritoneal transport during long CAPD dwells.
    Douma CE; Hiralall JK; de Waart DR; Struijk DG; Krediet RT
    Kidney Int; 1998 Apr; 53(4):1014-21. PubMed ID: 9551412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Use of icodextrin for diurnal exchange in patients undergoing automatic peritoneal dialysis. Comparison with glucose solutions].
    Bajo MA; Selgas R; del Peso G; Castro MJ; Hevia C; Gil F; Costero O; Olea T; Jiménez C
    Nefrologia; 2002; 22(4):348-55. PubMed ID: 12369126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.